Iichiro Shimomura Selected Research

Iichiro Shimomura Research Topics

Disease

115	Type 2 Diabetes Mellitus (MODY) 01/2024 - 07/2002
69	Obesity 11/2023 - 04/2002
65	Insulin Resistance 06/2022 - 05/2002
47	Atherosclerosis 12/2023 - 09/2002
37	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 03/2007
32	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023 - 07/2002
24	Hypertension (High Blood Pressure) 03/2024 - 01/2003
23	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 01/2010
22	Neoplasms (Cancer) 01/2022 - 01/2004
22	Hypoadiponectinemia 01/2017 - 09/2002
20	Inflammation (Inflammations) 01/2022 - 09/2006
19	Hyperglycemia 01/2022 - 03/2005
18	Diabetes Mellitus 03/2024 - 01/2003
18	Body Weight (Weight, Body) 01/2024 - 09/2003
16	Hypoglycemia (Reactive Hypoglycemia) 04/2022 - 01/2012
14	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 04/2002
13	Glucose Intolerance 11/2023 - 01/2009
12	Abdominal Obesity 07/2021 - 01/2003
11	Cushing Syndrome 11/2023 - 01/2013
11	Dyslipidemias (Dyslipidemia) 10/2023 - 01/2003
11	Carotid Artery Diseases 01/2023 - 11/2005
10	Hypoxia (Hypoxemia) 01/2024 - 10/2006
10	Hypertriglyceridemia 09/2022 - 06/2003
8	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2021 - 07/2010
7	Hyperaldosteronism (Conn Syndrome) 03/2024 - 01/2017
7	Hyperinsulinism (Hyperinsulinemia) 03/2022 - 10/2002
7	Heart Failure 03/2021 - 09/2005
6	COVID-19 05/2024 - 12/2021
6	Fibrosis (Cirrhosis) 05/2023 - 09/2007
6	Weight Loss (Weight Reduction) 01/2023 - 03/2012
6	Atherosclerotic Plaque (Atheroma) 11/2022 - 07/2007
6	Diabetic Nephropathies (Diabetic Nephropathy) 09/2022 - 01/2013
5	Diabetes Complications 10/2023 - 01/2019
5	Non-alcoholic Fatty Liver Disease 07/2023 - 05/2005
5	Peripheral Arterial Disease 04/2022 - 07/2012
5	Pituitary Neoplasms (Pituitary Adenoma) 12/2019 - 01/2012
5	Chronic Limb-Threatening Ischemia 07/2014 - 12/2010
5	Mason-Type Diabetes 12/2008 - 04/2005
5	Vascular Diseases (Vascular Disease) 04/2008 - 04/2002
4	Albuminuria 10/2023 - 09/2007
4	Liver Diseases (Liver Disease) 02/2023 - 10/2007
4	Pancreatitis 09/2022 - 01/2010
4	Chronic Renal Insufficiency 04/2022 - 01/2020
4	Hyperuricemia 04/2022 - 06/2011

Drug/Important Bio-Agent (IBA)

109	AdiponectinIBA 05/2024 - 05/2002
82	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 10/2002
65	Insulin (Novolin)FDA Link 11/2023 - 07/2002
25	AdipokinesIBA 05/2024 - 04/2002
25	Proteins (Proteins, Gene)FDA Link 09/2023 - 05/2002
18	Triglycerides (Triacylglycerol)IBA 06/2023 - 06/2003
17	Messenger RNA (mRNA)IBA 11/2022 - 04/2002
17	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2011
13	Hypoglycemic Agents (Hypoglycemics)IBA 12/2022 - 06/2005
13	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 01/2012
12	Glucagon (Glukagon)FDA Link 05/2022 - 01/2009
11	AlbuminsIBA 10/2023 - 09/2007
11	CholesterolIBA 11/2022 - 07/2003
11	HDL CholesterolIBA 01/2021 - 11/2005
10	LipidsIBA 10/2023 - 02/2011
10	Hemoglobins (Hemoglobin)IBA 10/2023 - 06/2011
10	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2023 - 01/2013
10	Hormones (Hormone)IBA 03/2021 - 10/2002
10	HDL LipoproteinsIBA 01/2021 - 02/2007
9	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023 - 12/2011
8	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2015
8	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2022 - 12/2011
8	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 01/2009
8	LigandsIBA 01/2022 - 06/2003
8	Blood Glucose (Blood Sugar)IBA 01/2020 - 12/2010
8	EnzymesIBA 05/2019 - 03/2006
8	Pioglitazone (Actos)FDA Link 01/2019 - 06/2005
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017 - 07/2002
7	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023 - 01/2013
7	alogliptinIBA 01/2023 - 01/2013
7	Sucrose (Saccharose)IBA 01/2021 - 01/2003
7	LeptinIBA 01/2011 - 05/2002
6	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2024 - 07/2013
6	AldosteroneIBA 03/2024 - 01/2017
6	Liraglutide FDA Link 01/2024 - 12/2011
6	Indicators and Reagents (Reagents)IBA 11/2023 - 09/2011
6	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2015
6	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 01/2023 - 10/2017
6	GlucocorticoidsIBA 12/2019 - 03/2012
6	CytokinesIBA 01/2019 - 09/2006
5	Transcription Factors (Transcription Factor)IBA 01/2024 - 02/2014
5	Uric Acid (Urate)IBA 02/2023 - 07/2012
5	H-cadherin (T-cadherin)IBA 12/2022 - 01/2017
5	C-PeptideIBA 01/2022 - 08/2017
5	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 12/2021 - 10/2009
5	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 01/2012
5	glimepiride (Amarel)FDA LinkGeneric 01/2020 - 06/2005
4	SodiumIBA 03/2024 - 10/2017
4	Endoplasmic Reticulum Chaperone BiPIBA 09/2023 - 04/2007
4	Xanthine DehydrogenaseIBA 07/2023 - 09/2013
4	purineIBA 07/2023 - 09/2013
4	Insulin Glargine (Lantus)FDA Link 02/2023 - 01/2012

Therapy/Procedure

46	Therapeutics 02/2023 - 07/2003
30	Glycemic Control 10/2023 - 12/2010
5	Transplantation 12/2019 - 10/2009
4	Bariatric Surgery 11/2023 - 01/2022